SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: Exacctnt who wrote (567)6/24/1998 12:11:00 PM
From: PAL  Read Replies (1) | Respond to of 1906
 
A month ago there was a rumor that DuPont would buy Amgen for $ 95. Gruntal's target is $ 82. Better act quick DuPont, or you'll have to buy at even higher price, which is OK with me.

Paul



To: Exacctnt who wrote (567)6/24/1998 12:20:00 PM
From: D.J.Smyth  Read Replies (1) | Respond to of 1906
 
it's about time. when are the analysts going to figure in the benefits of their new cancer drugs coming on line later this year? not a one has given a revenue value to these new drugs.